Passa al contenuto
Merck
Tutte le immagini(1)

Documenti fondamentali

89170

Sigma-Aldrich

Thorium oxide

≥99.0%

Autenticatiper visualizzare i prezzi riservati alla tua organizzazione & contrattuali


About This Item

Formula condensata:
ThO2
Numero CAS:
Peso molecolare:
264.04
Numero CE:
Numero MDL:
Codice UNSPSC:
12352300
ID PubChem:

Saggio

≥99.0%

Impiego in reazioni chimiche

reagent type: catalyst
core: thorium

Grado di funzionalizzazione

7.15 kBq/g specific activity

Stringa SMILE

O=[Th]=O

InChI

1S/2O.Th
ZCUFMDLYAMJYST-UHFFFAOYSA-N

Cerchi prodotti simili? Visita Guida al confronto tra prodotti

Attenzione

Regulations require a license for the sale of radioactive substances in Switzerland. Swiss customers are kindly requested when ordering, to include their license number, issued by the Swiss Public Health Authorities.

Altre note

Sales restrictions may apply
Regulations require a license for the sale of radioactive substances in Switzerland. Swiss customers are kindly requested when ordering, to include their license number, issued by the Swiss Public Health Authorities.

Pittogrammi

Health hazardSkull and crossbones

Avvertenze

Danger

Indicazioni di pericolo

Classi di pericolo

Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Carc. 1B - STOT RE 2

Codice della classe di stoccaggio

6.1D - Non-combustible acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects

Classe di pericolosità dell'acqua (WGK)

WGK 3

Punto d’infiammabilità (°F)

Not applicable

Punto d’infiammabilità (°C)

Not applicable


Scegli una delle versioni più recenti:

Certificati d'analisi (COA)

Lot/Batch Number

Non trovi la versione di tuo interesse?

Se hai bisogno di una versione specifica, puoi cercare il certificato tramite il numero di lotto.

Possiedi già questo prodotto?

I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.

Visita l’Archivio dei documenti

Yoichiro Yamamoto et al.
Health physics, 99(3), 388-393 (2010-08-12)
Irradiation from internally deposited radionuclides induces malignant tumors. Ingested radionuclides accumulate in specific organs, which are irradiated over a lifelong period. Our aim is to elucidate why the development of malignant tumors requires long-term internal exposure, on the order of
Daniel R McAlister et al.
Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine, 140, 18-23 (2018-06-25)
This work presents a complete scheme for the selective separation of actinium and radium isotopes from bulk 232Th target material, in a process that may be applied in a separation scheme for the production of 225Ac by proton spallation on
Rakesh K Behera et al.
Journal of physics. Condensed matter : an Institute of Physics journal, 24(21), 215405-215405 (2012-05-12)
Thorium dioxide (ThO(2)) is of great interest to energy research as thorium-based nuclear fuel offers the promise of increased proliferation resistance, longer fuel cycles, higher burn-up and improved wasteform characteristics in the generation of nuclear power. However, understanding of ThO(2)
[Carcinogenic chemicals and risk of hematopoietic neoplasms].
Masanobu Kobayashi
Nihon rinsho. Japanese journal of clinical medicine, 70 Suppl 2, 39-42 (2012-11-09)
Gopalakrishnan Balamurali et al.
Neurosurgery, 65(1), E210-E211 (2009-07-04)
Thorotrast was used as a contrast medium in clinical practice until the 1960s for outlining cerebral abscess cavities and ventricular cavities, and for angiography. Gliosarcomas, meningiomas, and schwannomas have been reported previously, as has Thorotrast-associated angiosarcoma, typically in the liver.

Il team dei nostri ricercatori vanta grande esperienza in tutte le aree della ricerca quali Life Science, scienza dei materiali, sintesi chimica, cromatografia, discipline analitiche, ecc..

Contatta l'Assistenza Tecnica.